ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 262 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,147 | -13.0% | 199 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $4,766 | +27.3% | 199 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $3,745 | +18.2% | 199 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $3,168 | -36.6% | 199 | -29.2% | 0.00% | -33.3% |
Q3 2022 | $5,000 | +25.0% | 281 | 0.0% | 0.00% | +50.0% |
Q2 2022 | $4,000 | -42.9% | 281 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $7,000 | +40.0% | 281 | 0.0% | 0.00% | +33.3% |
Q3 2021 | $5,000 | -28.6% | 281 | 0.0% | 0.00% | -25.0% |
Q2 2021 | $7,000 | 0.0% | 281 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $7,000 | -53.3% | 281 | 0.0% | 0.00% | -60.0% |
Q4 2020 | $15,000 | +15.4% | 281 | 0.0% | 0.01% | -23.1% |
Q2 2020 | $13,000 | -27.8% | 281 | -42.9% | 0.01% | +8.3% |
Q3 2019 | $18,000 | +28.6% | 492 | -5.7% | 0.01% | +33.3% |
Q2 2019 | $14,000 | 0.0% | 522 | 0.0% | 0.01% | -18.2% |
Q1 2019 | $14,000 | +27.3% | 522 | -5.1% | 0.01% | +120.0% |
Q3 2018 | $11,000 | – | 550 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |